| Treatment cost(a)(b)
| Difference(b)
|
---|
 | No program | Program | Absolute | % |
 | £8,325 | £7,708 | -£617 | -7.4 |
 | (£7,076 – £9,574) | (£6,444 – £8,972) | (-£2,394 – +£1,160) |  |
 | Health outcome(c)
| Difference(c)
|
 | No program | Program | Absolute | % |
Life-years | 10.89 | 11.25 | 0.36 | 3.3 |
 | (10.52 – 11.26) | (10.87 – 11.63) | (-0.17 – +0.89) |  |
QALE | 8.25 | 8.54 | 0.30 | 3.6 |
 | (7.98 – 8.51) | (8.27 – 8.81) | (-0.08 – +0.68) |  |
- (a) Treatment cost for diabetes-related complications from the UKPDS model using clinical data from the Australian patient sample
- (b) 95% confidence intervals in parentheses. Confidence interval for difference calculated as though independent estimates. These costs are health care costs associated with diabetes-related complications. They do not include ongoing care costs other than for complications. Costs reflect health care utilisation in the UK in the year 2000. Discount rate = 5% per annum
- (c) 95% confidence intervals in parentheses. Confidence interval for difference calculated as though independent estimates. Discount rate = 5% per annum.
-
Source: SHDGP Diabetes Program; UKPDS Outcomes Model [26]